Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?

Saved in:
Bibliographic Details
Published in:European heart journal 2014-08, Vol.35 (31), p.2055-2057
Main Author: Schuhlen, H.
Format: Article
Language:English
Subjects:
Acute Coronary Syndrome - drug therapy
Adenosine - analogs & derivatives
Adenosine - therapeutic use
Female
Humans
Male
Platelet Aggregation Inhibitors - therapeutic use
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3
cites cdi_FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3
container_end_page 2057
container_issue 31
container_start_page 2055
container_title European heart journal
container_volume 35
creator Schuhlen, H.
description
doi_str_mv 10.1093/eurheartj/ehu202
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1553707352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1553707352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3</originalsourceid><addsrcrecordid>eNo9UE1Lw0AUXESxtXr3JHv0knY_svnwIlL8goIeFLyFzeatSUm6cV-i9N-70lp48BjezPBmCLnkbM5ZLhcw-hq0H9YLqEfBxBGZciVElCexOiZTxnMVJUn2MSFniGvGWJbw5JRMRJwrluTxlNhXDxH2YBrbQEW_cU57h0NUO0NxLD-9G3uqN7rdIuAN1R7oT5gGwdMSrAvYeartELCmg290S2uN4QYb2oMPjA6q23NyYnWLcLHfM_L-cP-2fIpWL4_Py7tVZGTMh0hm2hoWawXClFVW5tqWTOYi0TwOP0ueKRGYaakMSCVCiDiVqUoBpBDCVHJGrne-vXdfI-BQdA0aaFu9ATdiwZWSKUuDNlDZjmq8Q_Rgi943nfbbgrPir93i0G6xazdIrvbuYxlSHQT_dcpfGV55KA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1553707352</pqid></control><display><type>article</type><title>Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?</title><source>Oxford Journals Online</source><creator>Schuhlen, H.</creator><creatorcontrib>Schuhlen, H.</creatorcontrib><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehu202</identifier><identifier>PMID: 24950694</identifier><language>eng</language><publisher>England</publisher><subject>Acute Coronary Syndrome - drug therapy ; Adenosine - analogs &amp; derivatives ; Adenosine - therapeutic use ; Female ; Humans ; Male ; Platelet Aggregation Inhibitors - therapeutic use ; Ticlopidine - analogs &amp; derivatives ; Ticlopidine - therapeutic use</subject><ispartof>European heart journal, 2014-08, Vol.35 (31), p.2055-2057</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3</citedby><cites>FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24950694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schuhlen, H.</creatorcontrib><title>Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><subject>Acute Coronary Syndrome - drug therapy</subject><subject>Adenosine - analogs &amp; derivatives</subject><subject>Adenosine - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Ticlopidine - analogs &amp; derivatives</subject><subject>Ticlopidine - therapeutic use</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9UE1Lw0AUXESxtXr3JHv0knY_svnwIlL8goIeFLyFzeatSUm6cV-i9N-70lp48BjezPBmCLnkbM5ZLhcw-hq0H9YLqEfBxBGZciVElCexOiZTxnMVJUn2MSFniGvGWJbw5JRMRJwrluTxlNhXDxH2YBrbQEW_cU57h0NUO0NxLD-9G3uqN7rdIuAN1R7oT5gGwdMSrAvYeartELCmg290S2uN4QYb2oMPjA6q23NyYnWLcLHfM_L-cP-2fIpWL4_Py7tVZGTMh0hm2hoWawXClFVW5tqWTOYi0TwOP0ueKRGYaakMSCVCiDiVqUoBpBDCVHJGrne-vXdfI-BQdA0aaFu9ATdiwZWSKUuDNlDZjmq8Q_Rgi943nfbbgrPir93i0G6xazdIrvbuYxlSHQT_dcpfGV55KA</recordid><startdate>20140814</startdate><enddate>20140814</enddate><creator>Schuhlen, H.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140814</creationdate><title>Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?</title><author>Schuhlen, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acute Coronary Syndrome - drug therapy</topic><topic>Adenosine - analogs &amp; derivatives</topic><topic>Adenosine - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Ticlopidine - analogs &amp; derivatives</topic><topic>Ticlopidine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schuhlen, H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schuhlen, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2014-08-14</date><risdate>2014</risdate><volume>35</volume><issue>31</issue><spage>2055</spage><epage>2057</epage><pages>2055-2057</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><cop>England</cop><pmid>24950694</pmid><doi>10.1093/eurheartj/ehu202</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2014-08, Vol.35 (31), p.2055-2057
issn 0195-668X
1522-9645
language eng
recordid cdi_proquest_miscellaneous_1553707352
source Oxford Journals Online
subjects Acute Coronary Syndrome - drug therapy
Adenosine - analogs & derivatives
Adenosine - therapeutic use
Female
Humans
Male
Platelet Aggregation Inhibitors - therapeutic use
Ticlopidine - analogs & derivatives
Ticlopidine - therapeutic use
title Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A23%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pre-specified%20vs.%20post-hoc%20subgroup%20analyses:%20are%20we%20wiser%20before%20or%20after%20a%20trial%20has%20been%20performed?&rft.jtitle=European%20heart%20journal&rft.au=Schuhlen,%20H.&rft.date=2014-08-14&rft.volume=35&rft.issue=31&rft.spage=2055&rft.epage=2057&rft.pages=2055-2057&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehu202&rft_dat=%3Cproquest_cross%3E1553707352%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c341t-38afc04a5e2cbd8b9afb03926a1424931852c347b5ce352950473757ee3222cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1553707352&rft_id=info:pmid/24950694&rfr_iscdi=true